4//SEC Filing
Ridha Essra 4
Accession 0001127602-21-028142
CIK 0001681087other
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 4:59 PM ET
Size
5.2 KB
Accession
0001127602-21-028142
Insider Transaction Report
Form 4
AVROBIO, Inc.AVRO
Ridha Essra
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-11-01+120,000→ 120,000 totalExercise: $5.67Exp: 2031-10-31→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]25% of the shares shall vest and become exercisable on November 1, 2022, and the remaining 75% shall vest in equal monthly installments thereafter over a 3 year period.
Documents
Issuer
AVROBIO, Inc.
CIK 0001681087
Entity typeother
Related Parties
1- filerCIK 0001888732
Filing Metadata
- Form type
- 4
- Filed
- Nov 1, 8:00 PM ET
- Accepted
- Nov 2, 4:59 PM ET
- Size
- 5.2 KB